Document Detail


T1-T2 Squamous Cell Carcinoma of the Uvula: A Little Big Enemy.
MedLine Citation:
PMID:  21900539     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objective. No specific epidemiology data are available for carcinoma of the uvula. This study aims to analyze the epidemiological characteristics and treatment outcomes of carcinoma of the uvula at the authors' institution.Study Design. Case series with chart review.Setting. Service of ENT-Head and Neck Surgery, University Hospital Complex of Santiago de Compostela (CHUS), Spain.Subjects and Methods. Retrospective epidemiological study of 21 male patients, mean age 57.52 years, diagnosed with squamous cell carcinoma of the uvula in the CHUS between January 1990 and June 2009.Results. Most patients presented with odynophagia and exophytic lesions microscopically consistent with moderately differentiated squamous cell carcinoma. Despite the size of the lesions (T1 and T2), more than half of the patients had lymph node metastases at diagnosis. More than 90.0% of patients with lesions larger than 1 cm presented with lymph node metastases. Although more than 70.0% of patients underwent a neck dissection in the first year after diagnosis, only 25.0% were free of metastatic disease. Recurrences occurred at a mean of 14 months from baseline in more than 50.0% of cases. Of the patients, 52.4% died, with a median survival of 38.15 months after diagnosis. The overall 5-year survival was 39.0%. According to tumor size, 5-year survival was 53.0% for T1 and 27.0% for T2.Conclusion. According to the data, clinical features of carcinoma of the uvula correspond with aggressive tumors, with rapid onset and a major negative impact regardless of tumor size at diagnosis. Early stage patients benefit significantly from surgical treatments with neck dissections.
Authors:
Federico Espinosa Restrepo; Gabriel Martínez Capoccioni; Carlos Martín Martín
Related Documents :
3953489 - Cisplatin as second-line chemotherapy in the treatment of advanced or recurrent leiomyo...
6275989 - Phase i-ii study of isotopic immunoglobulin therapy for primary liver cancer.
11561689 - A phase i trial of the oral platinum analogue jm216 with concomitant radiotherapy in ad...
872139 - Initial clinical study with pyrazofurin.
16443949 - Phase 1 trial of a cpg oligodeoxynucleotide for patients with recurrent glioblastoma.
22024039 - Multivariate prognostic study on node-positive gastric cancer: is tumor size a prognost...
18711189 - Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific...
23752739 - Gender-specific profiling in scn1a polymorphisms and time-to-recurrence in patients wit...
8063549 - Extended lymphadenectomy for rectal cancer: cure vs quality of life.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-7
Journal Detail:
Title:  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery     Volume:  -     ISSN:  1097-6817     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8508176     Medline TA:  Otolaryngol Head Neck Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Service of ENT-Head and Neck Surgery, University Hospital Complex of Santiago de Compostela (CHUS), Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predictors of Surgical Outcomes of Uvulopalatopharyngoplasty for Obstructive Sleep Apnea Hypopnea Sy...
Next Document:  Charles Taylor, Phronesis, and Medicine: Ethics and Interpretation in Illness Narrative.